Found: 14
Select item for more details and to access through your institution.
Nottingham prognostic x (NPx): a risk stratification tool in ER‐positive HER2‐negative breast cancer: a validation study.
- Published in:
- Histopathology, 2024, v. 85, n. 3, p. 468, doi. 10.1111/his.15234
- By:
- Publication type:
- Article
Characteristics and prognostic significance of polo‐like kinase‐1 (PLK1) expression in breast cancer.
- Published in:
- Histopathology, 2023, v. 83, n. 3, p. 414, doi. 10.1111/his.14960
- By:
- Publication type:
- Article
Evaluation oncotype DX<sup>®</sup> 21‐gene recurrence score and clinicopathological parameters: a single institutional experience.
- Published in:
- Histopathology, 2023, v. 82, n. 5, p. 755, doi. 10.1111/his.14863
- By:
- Publication type:
- Article
Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods.
- Published in:
- Histopathology, 2022, v. 81, n. 6, p. 786, doi. 10.1111/his.14781
- By:
- Publication type:
- Article
Visual assessment of mitotic figures in breast cancer: a comparative study between light microscopy and whole slide images.
- Published in:
- Histopathology, 2021, v. 79, n. 6, p. 913, doi. 10.1111/his.14543
- By:
- Publication type:
- Article
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study.
- Published in:
- Histopathology, 2021, v. 79, n. 6, p. 1087, doi. 10.1111/his.14542
- By:
- Publication type:
- Article
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1747, doi. 10.1038/s41416-023-02451-3
- By:
- Publication type:
- Article
AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00472-y
- By:
- Publication type:
- Article
AI‐based intra‐tumor heterogeneity score of Ki67 expression as a prognostic marker for early‐stage ER+/HER2− breast cancer.
- Published in:
- Journal of Pathology: Clinical Research, 2024, v. 10, n. 1, p. 1, doi. 10.1002/cjp2.346
- By:
- Publication type:
- Article
Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations.
- Published in:
- Journal of Pathology: Clinical Research, 2022, v. 8, n. 2, p. 116, doi. 10.1002/cjp2.256
- By:
- Publication type:
- Article
Reply to "Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10%".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 13, p. 2105, doi. 10.1002/cncr.34826
- By:
- Publication type:
- Article
The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long‐term follow‐up.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 8, p. 1183, doi. 10.1002/cncr.34655
- By:
- Publication type:
- Article
Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and Early-Stage Invasive Breast Cancers.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 9, p. 5053, doi. 10.3390/ijms25095053
- By:
- Publication type:
- Article
The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4060, doi. 10.3390/ijms25074060
- By:
- Publication type:
- Article